Tesamorelin for impaired cognitive function among PLWH History of Changes for Study: NCT02572323
History of Changes for Study: NCT02572323
It looks like this phase 2 study is now completed, it will be interesting to know what was the outcome!
"Tesamorelin is an injectable medication already approved by the U.S. FDA to treat abdominal fat accumulation in HIV. Abdominal fat accumulation is linked to memory and thinking difficulties, and previous studies have suggested that tesamorelin also may be beneficial for memory and thinking, but this has not been tested in HIV. The aim of this study is to test whether tesamorelin, in combination with a text-messaging application to help with motivation and adherence, will significantly improve memory and thinking in HIV."